USPTO serial 79349694
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joshua S. Jarvis, Esq.
Joshua S. Jarvis, Esq. Foley Hoag LLP155 Seaport BoulevardSeaport WestBoston, MA 02210-2600| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical use for testing blood; diagnostic preparations for medical use for testing bodily fluids; test strips for measuring blood glucose levels; reagents for medical use for testing blood; diagnostic testing materials for medical use in the form of reagent paper for measuring cholesterol, antibodies, blood cells, thyroid function, vitamin levels, female fertility, male fertility, hormone levels; chemical preparations for testing blood for medical purposes; medical diagnostic reagents and assays for testing bodily fluids | ACTIVE | — |
| 010 | Blood testing apparatus; blood testing equipment; apparatus for blood tests for medical use; apparatus for taking blood; medical apparatus for collecting blood; blood collecting tubules being blood testing apparatus; blood collection needles; blood collection tubes for medical use; blood lancets; disposable lancets for finger puncture; medical apparatus for taking bodily fluids; medical apparatus for collecting bodily fluids; bodily fluid collecting tubules for medical use; bodily fluids collection tubes for medical use; lancets; medical diagnostic testing apparatus for testing cholesterol, blood cell testing, antibodies, vaccine and immune response, thyroid function, diabetes, gout, iron levels, kidney function, liver function, muscle and bone health, vitamin levels, prostate antigens, female hormone levels, male hormone levels, allergies, blood groups, pregnancy and body inflammation; genetic testing apparatus for medical purposes; apparatus for DNA and RNA testing for medical purposes; medical apparatus for testing blood glucose levels; medical instruments for infectious disease testing; testing probes for medical diagnostic purposes; structural and replacement parts and fittings for the aforesaid goods | ACTIVE | — |
| 044 | Medical testing for diagnostic or treatment purposes in the field of cholesterol, blood cell testing, antibodies, vaccine and immune response, thyroid function, diabetes, gout, iron levels, kidney function, liver function, muscle and bone health, vitamin levels, prostate antigens, female hormone levels, male hormone levels, allergies, blood groups, pregnancy and body inflammation; medical testing for diagnostic purposes; medical testing for treatment purposes; medical testing services relating to the diagnosis of diseases; medical testing services relating to the treatment of diseases; genetic testing for medical purposes; medical testing for fitness evaluation; medical and health screening services relating to the DNA, genetics and genetic testing; health screening services in the field of cholesterol, blood cell testing, antibodies, vaccine and immune response, thyroid function, diabetes, gout, iron levels, kidney function, liver function, muscle and bone health, vitamin levels, prostate antigens, female hormone levels, male hormone levels, allergies, blood groups, pregnancy and body inflammation; medical screening services; drug screening for medical purposes; DNA screening for medical purposes; x-ray examinations for medical purposes; x-ray imaging for medical purposes; magnetic resonance imaging (MRI) services for medical purposes; virus testing services for medical diagnostic or treatment purposes; antibody testing services for medical diagnostic or treatment purposes; medical analysis of blood samples taken from patients for diagnostic and treatment purposes provided by medical laboratories; medical analysis of samples taken from patients for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the diagnosis and treatment of patients provided by medical laboratories; blood testing services for medical purposes; blood analysis services; bodily fluid testing services for medical purposes; bodily fluid analysis services for medical diagnostic or treatment purposes; weight management services, namely, providing weight loss and/or weight maintenance programs; weight reduction planning services; blood pressure screening services; cholesterol testing for medical diagnostic or treatment purposes; diabetes screening services; pregnancy testing services; testosterone testing services for medical diagnostic or treatment purposes; information, advice and consultancy relating to the aforesaid services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 13, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 18, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 18, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 16, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 16, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 16, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 12, 2023 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Dec 7, 2023 | APET | ASSIGNED TO PETITION STAFF | — |
| Nov 1, 2023 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Oct 31, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 31, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 31, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 11, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 11, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 11, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 27, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 26, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 26, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 26, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 4, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 11, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 11, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 30, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 29, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 24, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 16, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |